Board of Directors

2. Board of Directors R&D Director Matthew Wilcox • PhD in Human Physiology gNewcastle University • 6 years postdoctoral experience Managing and Financial Director Juliane Klein Marketing Director Laura Pascoe • MBA Business and Marketing gExeter University • 5 years Marketing at Unilever gLondon • MBA, FCA • Chartered accountant: PWC • Management consultancy: • Reed Cons. Operations Director Alessandra S. Dantas • MD University of Sao Paulo, MBA gHarvard University • 8 years Head of Department of Clinical gScience

3. Research and Development Tablet that you take before your main meal Forms a gel in the stomach Gives the feeling fullness Weight loss Reduction in bile re-uptake Therefore lowers cholesterol

4. Intellectual Property Time Line 2005 2006 2007 2008 University File Patent University File for PCT UK Patent Granted Prosecute in US, Canada, Europe, Japan, China and India

5. Pipe Line • Product Line • Different Vehicles for Administration • Different Flavours • Different Doses • Product Range • Diabetes prevention and control • Specific cholesterol lowering • Inhibition of Dietary Enzymes

6. Marketing and Sales Strategy

7. Overview, Drivers & Competition Source: 200 16+ males and females interviewed Newcastle and London • Food and supplement market £75 billion in Europe

8. Sales Strategy • 1 Million trial packs • Loss leader- viral marketing • Letters of intent

9. Operations

10. Operations - Production and Distribution Strategies Macclesfield Nottingham INDIA

11. Operations Structure of Fybre ltd.

12. Timeline and Milestones for Production of 1 million sample packets of Accelerol® 1 Buy in & shipment of raw material for WeightWatchers trial Accelerol® pressing and distribution to WeightWatchers trial 1-3 Months Stock piling and initial distribution to Boots, intensive advertising 4-7 Accelerol ® available to purchase from Boots nationwide 8

13. Financial Projections

14. Company Equity Share 10% 22.5% Your Investment Personal investment: £20,000/Director 22.5% 22.5% £80,000 for patent applications in Europe, USA, Canada, Japan, China, India Start of large scale production and product launch UK 22.5% Possible exit through IPO or Trade Sale Start of product trial through health clubs, Quality assurance Closing negotiations for whole sale to Danone, Unilever, Nestle Company set up (Ltd.) and University buy out: £80,000 (pref. shares) + 10% company BBSRC Entrepreneur Fellowship 1NE Research and Development Grant £100,000 2007 2008 2009 2010 2012 2011 2013 Initial Investment: £800,000 for 40% equity

15. Financial Projections Production cost/unit: £0.50 Unit price whole sale: £2.50 Company value after 5 years: £31 M

16. Thank You Sponsored by:

17. Balance Sheet Fybre ltd..xls

18. Cash Flow Fybre ltd.xls